The goal of this project is to address the following research question: Does the use of antidepressant treatment, specifically, selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs), reduce the risk of primary open angle glaucoma?
Antidepressant Use and the Risk of Primary Open Angle Glaucoma
Investigator: Jorgenson, Eric
Funder: Northern California Community Benefit Programs
